Dr. Lerner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
650 Albany St
EBRC 420
Boston, MA 02118Phone+1 617-638-7504- Is this information wrong?
Summary
- Dr. Adam Lerner is an oncologist in Boston, MA. He received his medical degree from Yale University School of Medicine and has been in practice 34 years, primarily at Boston University and Boston Medical Center. He has carried out translational research on cyclic nucleotide phosphodiesterase inhibitors as well as on a focal adhesion complex adapter protein, BCAR3/AND-34. He specializes in hematologic oncology, cutaneous oncology and soft tissue sarcomas.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1991
- Boston University Medical CenterResidency, Pathology-Anatomic and Clinical, 1986 - 1987
- Boston University Medical CenterResidency, Internal Medicine, 1983 - 1986
- Yale School of MedicineClass of 1983
- Amherst CollegeA.B., Biology, 1979
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- DOD Breast Cancer Idea Award 2001
- Career Development Award American Society of Clinical Oncology, 1998
- Leukemia Society of America Translational Research Award 1997
- Join now to see all
Clinical Trials
- Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2004 Apr 01
- Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma Start of enrollment: 2008 Dec 15
- Everolimus in Treating Cutaneous T-cell Lymphoma Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Primary intracranial extraosseous Ewing's sarcoma of the skull base in an elderly adult: illustrative case.Kristine Ravina, Sonora A Windermere, Qing Zhao, Adam Lerner, Michael Dyer, Urvashi Upadhyay, R Tushar Jha> ;Journal of Neurosurgery. Case Lessons. 2022 Oct 17
- 1 citationsStandard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Am...David M Hughes, Lynnette Henshaw, Frances Blevins, Camille Edwards, Adam Lerner, John Mark Sloan, Vaishali Sanchorawala> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Aug 1
- 1 citationsUnderrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma.Charles J Milrod, Michael Mann, Frances Blevins, David Hughes, Preya Patel, Katie Y Li, Adam Lerner, Vaishali Sanchorawala, J Mark Sloan> ;Critical Reviews in Oncology/hematology. 2022 Apr 1
- Join now to see all
Journal Articles
- Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphomaSchieke SM, Sharaf M, Lerner A, Runger T, Mahalingam M, J. Cutan. Pathol, 1/1/2012
- AND-34/BCAR3 augments the ability of p130Cas to bind the Src SH3 domain in a BCAR3-p130Cas complex-dependent mannerMakkinje A, VandenBorre P, Near RI, Patel P and Lerner A, J. Biol. Chem, 1/1/2012
- Chemotherapy as treatment for colocolonic intussusception associated with acquired immunodeficiency-related lymphomaLerner A, Soto J and Rosen J, Surgery, 1/1/2011
- Join now to see all
Books/Book Chapters
Press Mentions
- Matthew Kulke, MD, Joins BUMCNovember 21st, 2017
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
- Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: